Form 4: Relay Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Brian Adams, Chief Legal Officer of Relay Therapeutics, sold 1,638 shares of common stock to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- On July 29, 2024, Brian Adams, the Chief Legal Officer of Relay Therapeutics, sold 1,638 shares of the company's common stock.
- The sale was executed at a price of $8.85 per share.
- This transaction was to cover income tax withholding obligations related to the vesting of 5,505 restricted stock units (RSUs) on July 27, 2024.
- Following the transaction, Adams beneficially owns 323,834 shares, including 284,823 shares underlying RSUs.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by a company officer. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders and officers, providing transparency into their transactions in the company's stock. These filings are closely watched by investors for insights into management's perspective on the company's valuation and future prospects.
Key Dates
| Date | Description |
|---|---|
| 07/27/2024 | Vesting of 5,505 shares of restricted stock units (RSUs) |
| 07/29/2024 | Sale of 1,638 shares of common stock by Brian Adams |
| 07/31/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.